OCULIS HOLDING AG (OCS) Fundamental Analysis & Valuation

NASDAQ:OCS • CH1242303498

Current stock price

24.69 USD
-0.3 (-1.2%)
At close:
24.69 USD
0 (0%)
After Hours:

This OCS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. OCS Profitability Analysis

1.1 Basic Checks

  • In the past year OCS has reported negative net income.
  • In the past year OCS has reported a negative cash flow from operations.
  • OCS had negative earnings in each of the past 5 years.
  • OCS had a negative operating cash flow in each of the past 5 years.
OCS Yearly Net Income VS EBIT VS OCF VS FCFOCS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 -20M -40M -60M -80M

1.2 Ratios

  • The Return On Assets of OCS (-41.94%) is worse than 60.10% of its industry peers.
  • OCS's Return On Equity of -50.47% is in line compared to the rest of the industry. OCS outperforms 51.30% of its industry peers.
Industry RankSector Rank
ROA -41.94%
ROE -50.47%
ROIC N/A
ROA(3y)-63.62%
ROA(5y)-65.45%
ROE(3y)-87.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OCS Yearly ROA, ROE, ROICOCS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 -50 -100

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for OCS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OCS Yearly Profit, Operating, Gross MarginsOCS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. OCS Health Analysis

2.1 Basic Checks

  • The number of shares outstanding for OCS has been increased compared to 1 year ago.
  • The number of shares outstanding for OCS has been increased compared to 5 years ago.
  • Compared to 1 year ago, OCS has about the same debt to assets ratio.
OCS Yearly Shares OutstandingOCS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
OCS Yearly Total Debt VS Total AssetsOCS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

  • An Altman-Z score of 16.04 indicates that OCS is not in any danger for bankruptcy at the moment.
  • OCS's Altman-Z score of 16.04 is amongst the best of the industry. OCS outperforms 89.64% of its industry peers.
  • OCS has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of OCS (0.01) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 16.04
ROIC/WACCN/A
WACCN/A
OCS Yearly LT Debt VS Equity VS FCFOCS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • OCS has a Current Ratio of 5.96. This indicates that OCS is financially healthy and has no problem in meeting its short term obligations.
  • OCS has a better Current ratio (5.96) than 69.95% of its industry peers.
  • OCS has a Quick Ratio of 5.96. This indicates that OCS is financially healthy and has no problem in meeting its short term obligations.
  • OCS has a better Quick ratio (5.96) than 70.47% of its industry peers.
Industry RankSector Rank
Current Ratio 5.96
Quick Ratio 5.96
OCS Yearly Current Assets VS Current LiabilitesOCS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. OCS Growth Analysis

3.1 Past

  • OCS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.57%, which is quite good.
EPS 1Y (TTM)8.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.31%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13600%

3.2 Future

  • OCS is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.13% yearly.
  • Based on estimates for the next years, OCS will show a very strong growth in Revenue. The Revenue will grow by 263.90% on average per year.
EPS Next Y1.43%
EPS Next 2Y-4.01%
EPS Next 3Y32.47%
EPS Next 5Y24.13%
Revenue Next Year763.81%
Revenue Next 2Y621.15%
Revenue Next 3Y445.91%
Revenue Next 5Y263.9%

3.3 Evolution

OCS Yearly Revenue VS EstimatesOCS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B
OCS Yearly EPS VS EstimatesOCS Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 2 -2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. OCS Valuation Analysis

4.1 Price/Earnings Ratio

  • OCS reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OCS. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OCS Price Earnings VS Forward Price EarningsOCS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OCS Per share dataOCS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • A more expensive valuation may be justified as OCS's earnings are expected to grow with 32.47% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-4.01%
EPS Next 3Y32.47%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. OCS Dividend Analysis

5.1 Amount

  • OCS does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

OCS Fundamentals: All Metrics, Ratios and Statistics

OCULIS HOLDING AG

NASDAQ:OCS (3/27/2026, 8:00:01 PM)

After market: 24.69 0 (0%)

24.69

-0.3 (-1.2%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-03
Earnings (Next)05-07
Inst Owners39.88%
Inst Owner ChangeN/A
Ins Owners2.75%
Ins Owner ChangeN/A
Market Cap1.26B
Revenue(TTM)N/A
Net Income(TTM)-98.96M
Analysts86.67
Price Target48.14 (94.98%)
Short Float %1.25%
Short Ratio1.8
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.43%
Min EPS beat(2)1.62%
Max EPS beat(2)25.25%
EPS beat(4)2
Avg EPS beat(4)-8.46%
Min EPS beat(4)-56.2%
Max EPS beat(4)25.25%
EPS beat(8)3
Avg EPS beat(8)-15.67%
EPS beat(12)4
Avg EPS beat(12)-14.6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)117.55%
Min Revenue beat(2)24.83%
Max Revenue beat(2)210.28%
Revenue beat(4)4
Avg Revenue beat(4)75.15%
Min Revenue beat(4)24.83%
Max Revenue beat(4)210.28%
Revenue beat(8)4
Avg Revenue beat(8)21.28%
Revenue beat(12)7
Avg Revenue beat(12)40.6%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)7.27%
PT rev (3m)7.27%
EPS NQ rev (1m)13.77%
EPS NQ rev (3m)13.77%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-1.89%
Revenue NQ rev (3m)-1.89%
Revenue NY rev (1m)9.19%
Revenue NY rev (3m)9.19%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 5.12
P/tB 5.49
EV/EBITDA N/A
EPS(TTM)-2.41
EYN/A
EPS(NY)-2.37
Fwd EYN/A
FCF(TTM)-1.67
FCFYN/A
OCF(TTM)-1.63
OCFYN/A
SpS0
BVpS4.83
TBVpS4.5
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -41.94%
ROE -50.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-63.62%
ROA(5y)-65.45%
ROE(3y)-87.37%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 254.21%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.96
Quick Ratio 5.96
Altman-Z 16.04
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)109.2%
Cap/Depr(5y)304.68%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.31%
EPS Next Y1.43%
EPS Next 2Y-4.01%
EPS Next 3Y32.47%
EPS Next 5Y24.13%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%13600%
Revenue Next Year763.81%
Revenue Next 2Y621.15%
Revenue Next 3Y445.91%
Revenue Next 5Y263.9%
EBIT growth 1Y-11.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-27.32%
EBIT Next 3Y55.03%
EBIT Next 5Y40.94%
FCF growth 1Y-37.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-35.54%
OCF growth 3YN/A
OCF growth 5YN/A

OCULIS HOLDING AG / OCS Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for OCULIS HOLDING AG?

ChartMill assigns a fundamental rating of 2 / 10 to OCS.


Can you provide the valuation status for OCULIS HOLDING AG?

ChartMill assigns a valuation rating of 1 / 10 to OCULIS HOLDING AG (OCS). This can be considered as Overvalued.


Can you provide the profitability details for OCULIS HOLDING AG?

OCULIS HOLDING AG (OCS) has a profitability rating of 0 / 10.


What is the expected EPS growth for OCULIS HOLDING AG (OCS) stock?

The Earnings per Share (EPS) of OCULIS HOLDING AG (OCS) is expected to grow by 1.43% in the next year.